|
EP0673240B1
(en)
*
|
1992-12-09 |
1999-03-24 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Stabilized medicinal aerosol solution formulations
|
|
AU4655596A
(en)
*
|
1995-01-17 |
1996-08-07 |
Omega Pharmaceutical, Incorporated |
Liquid stable vitamin c compositions and delivery systems, and methods of making and uses thereof
|
|
US5653961A
(en)
*
|
1995-03-31 |
1997-08-05 |
Minnesota Mining And Manufacturing Company |
Butixocort aerosol formulations in hydrofluorocarbon propellant
|
|
DE69637257T2
(de)
*
|
1995-04-14 |
2008-06-12 |
Smithkline Beecham Corp. |
Verfahren zur Herstellung eines Dosierinhalators
|
|
CZ288337B6
(en)
|
1995-06-27 |
2001-05-16 |
Boehringer Ingelheim Kg |
Pharmaceutical preparation
|
|
DE19528145A1
(de)
*
|
1995-08-01 |
1997-02-06 |
Boehringer Ingelheim Kg |
Neue Arzneimittel und ihre Verwendung
|
|
US6054488A
(en)
*
|
1996-06-11 |
2000-04-25 |
3M Innovative Properties Company |
Medicinal aerosol formulations of formoterol
|
|
GB9616237D0
(en)
*
|
1996-08-01 |
1996-09-11 |
Norton Healthcare Ltd |
Aerosol formulations
|
|
DE19653969A1
(de)
*
|
1996-12-20 |
1998-06-25 |
Boehringer Ingelheim Kg |
Neue wässrige Arzneimittelzubereitung zur Erzeugung treibgasfreier Aerosole
|
|
US20030215396A1
(en)
|
1999-09-15 |
2003-11-20 |
Boehringer Ingelheim Pharma Kg |
Method for the production of propellant gas-free aerosols from aqueous medicament preparations
|
|
NZ336381A
(en)
|
1996-12-30 |
2000-11-24 |
Battelle Memorial Institute |
Formulation and method for treating neoplasms by inhalation
|
|
CZ296966B6
(cs)
*
|
1997-02-24 |
2006-08-16 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Farmaceutický prostredek
|
|
GB2326334A
(en)
*
|
1997-06-13 |
1998-12-23 |
Chiesi Farma Spa |
Pharmaceutical aerosol compositions
|
|
US20010031244A1
(en)
*
|
1997-06-13 |
2001-10-18 |
Chiesi Farmaceutici S.P.A. |
Pharmaceutical aerosol composition
|
|
WO1999045777A1
(en)
*
|
1998-03-10 |
1999-09-16 |
The Children's Hospital Of Philadelphia |
Compositions and methods for treatment of asthma
|
|
EP1087750B1
(en)
*
|
1998-06-18 |
2003-11-12 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Pharmaceutical formulations for aerosols with two or more active substances
|
|
US6451285B2
(en)
*
|
1998-06-19 |
2002-09-17 |
Baker Norton Pharmaceuticals, Inc. |
Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
|
|
DE19847968A1
(de)
*
|
1998-10-17 |
2000-04-20 |
Boehringer Ingelheim Pharma |
Verschlußkappe und Behälter als Zweikammer-Kartusche für Vernebler zur Erzeugung von Aerosolen
|
|
DZ2947A1
(fr)
*
|
1998-11-25 |
2004-03-15 |
Chiesi Farma Spa |
Inhalateur à compteur de dose sous pression.
|
|
GB9902689D0
(en)
*
|
1999-02-08 |
1999-03-31 |
Novartis Ag |
Organic compounds
|
|
DE19921693A1
(de)
*
|
1999-05-12 |
2000-11-16 |
Boehringer Ingelheim Pharma |
Neuartige Arzneimittelkompositionen auf der Basis von anticholinergisch wirksamen Verbindungen und ß-Mimetika
|
|
US20040002548A1
(en)
*
|
1999-05-12 |
2004-01-01 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US20100197719A1
(en)
*
|
1999-05-12 |
2010-08-05 |
Boehringer Ingelheim Pharma Kg |
Medicament compositions containing anticholinergically-effective compounds and betamimetics
|
|
US6315985B1
(en)
*
|
1999-06-18 |
2001-11-13 |
3M Innovative Properties Company |
C-17/21 OH 20-ketosteroid solution aerosol products with enhanced chemical stability
|
|
ES2165768B1
(es)
|
1999-07-14 |
2003-04-01 |
Almirall Prodesfarma Sa |
Nuevos derivados de quinuclidina y composiciones farmaceuticas que los contienen.
|
|
IT1313553B1
(it)
|
1999-07-23 |
2002-09-09 |
Chiesi Farma Spa |
Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
|
|
DE60031504T2
(de)
|
1999-09-11 |
2007-04-05 |
Glaxo Group Ltd., Greenford |
Fluticasonpropionat arzneizubereitung
|
|
WO2001047493A1
(en)
*
|
1999-12-24 |
2001-07-05 |
Glaxo Group Limited |
Pharmaceutical aerosol formulation of salmeterol and fluticasone propionate
|
|
IT1317720B1
(it)
*
|
2000-01-07 |
2003-07-15 |
Chiesi Farma Spa |
Dispositivo per la somministrazione di aerosol dosati pressurizzati inpropellenti idrofluoroalcani.
|
|
IT1317846B1
(it)
|
2000-02-22 |
2003-07-15 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
|
|
IT1318514B1
(it)
*
|
2000-05-12 |
2003-08-27 |
Chiesi Farma Spa |
Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
|
|
CN1213732C
(zh)
|
2000-05-22 |
2005-08-10 |
奇斯药制品公司 |
用于加压计量吸入器的稳定药用溶液制剂
|
|
CA2425539C
(en)
*
|
2000-10-12 |
2007-04-03 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Crystalline monohydrate, processes for the preparation thereof and the use thereof for preparing a pharmaceutical composition
|
|
US6908928B2
(en)
|
2000-10-12 |
2005-06-21 |
Bi Pharma Kg. |
Crystalline tiotropium bromide monohydrate, processes for the preparation thereof, and pharmaceutical compositions
|
|
US6620438B2
(en)
*
|
2001-03-08 |
2003-09-16 |
Boehringer Ingelheim Pharma Kg |
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
|
|
US7776315B2
(en)
*
|
2000-10-31 |
2010-08-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Pharmaceutical compositions based on anticholinergics and additional active ingredients
|
|
DE10063957A1
(de)
*
|
2000-12-20 |
2002-06-27 |
Boehringer Ingelheim Pharma |
Neue Arzneimittelkompositionen auf der Basis von Anticholinergika und Dopamin-Agonisten
|
|
US20020085978A1
(en)
*
|
2000-11-10 |
2002-07-04 |
Mina Buenafe |
Degradation-resistant glucocorticosteroid formulations
|
|
US20100310477A1
(en)
*
|
2000-11-28 |
2010-12-09 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg. |
Pharmaceutical compositions based on anticholingerics and additional active ingredients
|
|
EP1241113A1
(en)
|
2001-03-12 |
2002-09-18 |
CHIESI FARMACEUTICI S.p.A. |
Inhaler with means for improving chemical stability of medicinal aerosol solution contained therein
|
|
DE10111843A1
(de)
*
|
2001-03-13 |
2002-09-19 |
Boehringer Ingelheim Pharma |
Verbindungen zur Behandlung von inflammatorischen Erkrankungen
|
|
US6455028B1
(en)
|
2001-04-23 |
2002-09-24 |
Pharmascience |
Ipratropium formulation for pulmonary inhalation
|
|
US20050070487A1
(en)
*
|
2001-04-24 |
2005-03-31 |
Nyce Jonathan W. |
Composition, formulations and kit for treatment of respiratory and lung disease with non-glucocorticoid steroids and/or ubiquinone and a bronchodilating agent
|
|
EP1273292B1
(en)
|
2001-07-02 |
2004-05-26 |
CHIESI FARMACEUTICI S.p.A. |
Optimised formulation of tobramycin for aerosolization
|
|
DE10135355C1
(de)
*
|
2001-07-20 |
2003-04-17 |
Schering Ag |
Konjugate makrocyclischer Metallkomplexe mit Biomolekülen und deren Verwendung zur Herstellung von Mitteln für die NMR- und Radiodiagnostik sowie die Radiotherapie
|
|
DK1446119T3
(da)
|
2001-09-18 |
2006-07-10 |
Nycomed Danmark Aps |
Præparater omfattende Ipratropium og xylometazolin til behandling af almindelig forkölelse
|
|
AU3297402A
(en)
*
|
2001-10-26 |
2003-10-30 |
Dey, L.P. |
An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
CA2464660C
(en)
*
|
2001-10-26 |
2011-12-20 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
|
US8084461B2
(en)
|
2001-10-26 |
2011-12-27 |
Dey, L.P. |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
JP2003221335A
(ja)
|
2001-10-26 |
2003-08-05 |
Dey Lp |
慢性閉塞性肺疾患の症状を緩和するためのアルブテロールおよびイプラトロピウム吸入溶液、システム、キットおよび方法
|
|
US6702997B2
(en)
|
2001-10-26 |
2004-03-09 |
Dey, L.P. |
Albuterol inhalation solution, system, kit and method for relieving symptoms of pediatric asthma
|
|
US20030140920A1
(en)
*
|
2001-10-26 |
2003-07-31 |
Dey L.P. |
Albuterol inhalation soultion, system, kit and method for relieving symptoms of pediatric asthma
|
|
US20030191151A1
(en)
*
|
2001-10-26 |
2003-10-09 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
US20030203930A1
(en)
*
|
2001-10-26 |
2003-10-30 |
Imtiaz Chaudry |
Albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
|
|
DE10161368A1
(de)
*
|
2001-12-14 |
2003-07-10 |
Messer Griesheim Gmbh |
Vorrichtung und Verfahren zum kryogenen Abfüllen von Aerosol-Produktansätzen
|
|
CA2470498A1
(en)
|
2001-12-21 |
2003-07-24 |
3M Innovative Properties Company |
Medicinal aerosol compositions with an amide and/or ester containing excipient compound
|
|
AU2002361850A1
(en)
*
|
2001-12-21 |
2003-07-30 |
3M Innovative Properties Company |
Medicinal aerosol formulations comprising ion pair complexes
|
|
JP4959919B2
(ja)
|
2001-12-21 |
2012-06-27 |
スリーエム イノベイティブ プロパティズ カンパニー |
官能基を有するポリエチレングリコール賦形剤を用いた医薬用エアロゾル組成物
|
|
AU2003222753B2
(en)
|
2002-03-01 |
2008-04-17 |
Chiesi Farmaceutici S.P.A. |
Formoterol superfine formulation
|
|
US20040126325A1
(en)
*
|
2002-03-12 |
2004-07-01 |
David Lewis |
Medicinal aerosol solution formulation products with improved chemical stability
|
|
US7311894B2
(en)
*
|
2002-03-28 |
2007-12-25 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations containing an anticholinergic
|
|
US7244415B2
(en)
|
2002-03-28 |
2007-07-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
HFA suspension formulations of an anhydrate
|
|
WO2003099207A2
(en)
*
|
2002-05-24 |
2003-12-04 |
Agennix Incorporated |
Oral lactoferrin in the treatment of respiratory disorders
|
|
WO2004014293A2
(en)
*
|
2002-06-12 |
2004-02-19 |
Epigenesis Pharmaceuticals, Inc. |
Combination of anti-muscarinic agents and non-glucocorticoid steroids
|
|
US7056916B2
(en)
*
|
2002-11-15 |
2006-06-06 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Medicaments for the treatment of chronic obstructive pulmonary disease
|
|
US20050058606A1
(en)
*
|
2002-12-16 |
2005-03-17 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Tiotropium containing HFC solution formulations
|
|
BR0317340A
(pt)
*
|
2002-12-16 |
2005-11-08 |
Boehringer Ingelheim Pharma |
Formulações de hfc em solução contendo tiotrópio
|
|
HRP20050822B1
(hr)
*
|
2003-03-20 |
2013-09-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Formulacija za inhalator s odmjerenom dozom koji koristi hidro-fluoro-alkane kao propelente
|
|
EP1915985A1
(en)
*
|
2003-03-20 |
2008-04-30 |
Boehringer Ingelheim Pharmaceuticals Inc. |
Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
|
|
US7273603B2
(en)
*
|
2003-07-11 |
2007-09-25 |
Boehringer Ingelheim International Gmbh |
HFC solution formulations containing an anticholinergic
|
|
US20050026948A1
(en)
*
|
2003-07-29 |
2005-02-03 |
Boehringer Ingelheim International Gmbh |
Medicaments for inhalation comprising an anticholinergic and a betamimetic
|
|
US20050038004A1
(en)
*
|
2003-07-31 |
2005-02-17 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050026882A1
(en)
*
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20090317476A1
(en)
*
|
2003-07-31 |
2009-12-24 |
Robinson Cynthia B |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a leukotriene receptor antagonist for treatment of asthma or chronic obstructive pulmonary disease
|
|
US20050101545A1
(en)
*
|
2003-07-31 |
2005-05-12 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anticholinergic bronchodilator for treatment of asthma or chronic obstructive pulmonary disease
|
|
AR041873A1
(es)
*
|
2003-10-30 |
2005-06-01 |
Pablo Cassara Srl Lab |
Una formulacion farmaceutica en aerosol adecuada para la inhalacion oral o nasal que contienen glucocorticoides en solucion estable al almacenamiento; un metodo para estabilzar formulaciones y uso de un agente estabilizante
|
|
EP1595531A1
(en)
*
|
2004-05-13 |
2005-11-16 |
CHIESI FARMACEUTICI S.p.A. |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
|
IL177103A0
(en)
*
|
2004-02-27 |
2006-12-10 |
Chiesi Farma Spa |
Stable pharmaceutical solution formulations for pressurized metered dose inhalers
|
|
US20050255050A1
(en)
*
|
2004-05-14 |
2005-11-17 |
Boehringer Ingelheim International Gmbh |
Powder formulations for inhalation, comprising enantiomerically pure beta agonists
|
|
US7220742B2
(en)
|
2004-05-14 |
2007-05-22 |
Boehringer Ingelheim International Gmbh |
Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
|
|
ES2257152B1
(es)
*
|
2004-05-31 |
2007-07-01 |
Laboratorios Almirall S.A. |
Combinaciones que comprenden agentes antimuscarinicos y agonistas beta-adrenergicos.
|
|
MXPA06015204A
(es)
*
|
2004-07-02 |
2007-03-15 |
Boehringer Ingelheim Int |
Formulaciones en suspension de aerosol con tg 227 ea o tg 134 a como agentes propulsores.
|
|
GB0501956D0
(en)
*
|
2005-01-31 |
2005-03-09 |
Arrow Internat |
Nebulizer formulation
|
|
UA92732C2
(ru)
*
|
2005-02-25 |
2010-12-10 |
КЬЕЗИ ФАРМАЧЕУТИЧИ С.п.А. |
Фармацевтические аэрозольные композиции для ингаляторов под давлением с вымеренными дозами, которые содержат связующее соединение
|
|
CA2607391A1
(en)
*
|
2005-04-23 |
2006-11-02 |
Boehringer Ingelheim International Gmbh |
Combination of medicaments to be inhaled, containing a betamimetic agent and a steroid in addition to an anticholinergic agent
|
|
DK1881980T3
(da)
|
2005-05-02 |
2012-10-01 |
Boehringer Ingelheim Int |
Nye krystalline former af tiotropiumbromid
|
|
WO2007020227A1
(de)
*
|
2005-08-15 |
2007-02-22 |
Boehringer Ingelheim International Gmbh |
Verfahren zur herstellung von betamimetika
|
|
WO2007034207A2
(en)
*
|
2005-09-25 |
2007-03-29 |
Cipla Limited |
Troventol formulation
|
|
US20070088030A1
(en)
*
|
2005-10-10 |
2007-04-19 |
Barbara Niklaus-Humke |
Aerosol formulations for the inhalation of beta-agonists
|
|
TWI396541B
(zh)
*
|
2005-10-10 |
2013-05-21 |
Boehringer Ingelheim Int |
用於治療呼吸疾病之新穎藥物組合
|
|
DE102006017320A1
(de)
|
2006-04-11 |
2007-10-18 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
|
|
DE102006023770A1
(de)
*
|
2006-05-20 |
2007-11-22 |
Boehringer Ingelheim Pharma Gmbh & Co. Kg |
Treibgasfreie Aerosolformulierung für die Inhalation
|
|
WO2008008494A2
(en)
*
|
2006-07-13 |
2008-01-17 |
Accentia Biopharmaceuticals, Inc. |
Methods and compositions for treating mucosal inflammation
|
|
EP2077132A1
(en)
|
2008-01-02 |
2009-07-08 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dispensing device, storage device and method for dispensing a formulation
|
|
EP2100599A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2100598A1
(en)
|
2008-03-13 |
2009-09-16 |
Laboratorios Almirall, S.A. |
Inhalation composition containing aclidinium for treatment of asthma and chronic obstructive pulmonary disease
|
|
EP2201934A1
(en)
|
2008-12-23 |
2010-06-30 |
CHIESI FARMACEUTICI S.p.A. |
Tiotropium aerosol formulation products with improved chemical stability
|
|
US10011906B2
(en)
|
2009-03-31 |
2018-07-03 |
Beohringer Ingelheim International Gmbh |
Method for coating a surface of a component
|
|
EP3508239B1
(de)
|
2009-05-18 |
2020-12-23 |
Boehringer Ingelheim International GmbH |
Adapter, inhalationseinrichtung und zerstäuber
|
|
MX2012005711A
(es)
|
2009-11-17 |
2012-10-05 |
Cipla Ltd |
Soluciones de inhalacion.
|
|
EA026241B1
(ru)
|
2009-11-25 |
2017-03-31 |
Бёрингер Ингельхайм Интернациональ Гмбх |
Распылитель
|
|
JP5658268B2
(ja)
|
2009-11-25 |
2015-01-21 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
|
US10016568B2
(en)
|
2009-11-25 |
2018-07-10 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
|
EP2512438B1
(en)
|
2009-12-16 |
2017-01-25 |
3M Innovative Properties Company |
Formulations and methods for controlling mdi particle size delivery
|
|
RS53391B2
(sr)
*
|
2009-12-23 |
2023-09-29 |
Chiesi Farm Spa |
Kombinovana terapija copd-a (hroničnih obstruktivnih bolesti pluća)
|
|
WO2011076842A2
(en)
|
2009-12-23 |
2011-06-30 |
Chiesi Farmaceutici S.P.A. |
Aerosol formulation for copd
|
|
JP5874724B2
(ja)
|
2010-06-24 |
2016-03-02 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
ネブライザ
|
|
JP5409594B2
(ja)
*
|
2010-12-22 |
2014-02-05 |
キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ |
加圧式定量吸入器のための安定な製薬学的溶液製剤
|
|
US20120204871A1
(en)
*
|
2011-02-10 |
2012-08-16 |
Julio Cesar Vega |
Stable, non-corrosive formulations for pressurized metered dose inhalers
|
|
EP2694220B1
(de)
|
2011-04-01 |
2020-05-06 |
Boehringer Ingelheim International GmbH |
Medizinisches gerät mit behälter
|
|
EP2510928A1
(en)
|
2011-04-15 |
2012-10-17 |
Almirall, S.A. |
Aclidinium for use in improving the quality of sleep in respiratory patients
|
|
US9827384B2
(en)
|
2011-05-23 |
2017-11-28 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
|
GB201200504D0
(en)
|
2011-12-19 |
2012-02-22 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhaler
|
|
GB201200525D0
(en)
|
2011-12-19 |
2012-02-29 |
Teva Branded Pharmaceutical Prod R & D Inc |
An inhalable medicament
|
|
JP6335798B2
(ja)
|
2012-02-28 |
2018-05-30 |
ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング |
新規噴射剤含有チオトロピウム製剤
|
|
WO2013152894A1
(de)
|
2012-04-13 |
2013-10-17 |
Boehringer Ingelheim International Gmbh |
Zerstäuber mit kodiermitteln
|
|
RU2496477C1
(ru)
*
|
2012-09-20 |
2013-10-27 |
Шолекс Девелопмент Гмбх |
Раствор ипратропия бромида
|
|
RU2519653C1
(ru)
*
|
2013-02-27 |
2014-06-20 |
Шолекс Девелопмент Гмбх, |
Аэрозольный препарат на основе ипратропия бромида для лечения заболеваний органов дыхания
|
|
EP3030298B1
(en)
|
2013-08-09 |
2017-10-11 |
Boehringer Ingelheim International GmbH |
Nebulizer
|
|
ES2836977T3
(es)
|
2013-08-09 |
2021-06-28 |
Boehringer Ingelheim Int |
Nebulizador
|
|
RU2536253C1
(ru)
*
|
2013-10-09 |
2014-12-20 |
Шолекс Девелопмент Гмбх |
Комбинированный аэрозольный препарат для лечения болезней органов дыхания
|
|
WO2015077574A1
(en)
|
2013-11-22 |
2015-05-28 |
Teva Branded Pharmaceutical Products R&D, Inc. |
An inhalable medicament
|
|
WO2015077594A1
(en)
*
|
2013-11-22 |
2015-05-28 |
Teva Branded Pharmaceutical Products R&D, Inc. |
An inhalable medicament
|
|
ES2874029T3
(es)
|
2014-05-07 |
2021-11-04 |
Boehringer Ingelheim Int |
Nebulizador
|
|
WO2015169732A1
(en)
|
2014-05-07 |
2015-11-12 |
Boehringer Ingelheim International Gmbh |
Container, nebulizer and use
|
|
AU2015258107B2
(en)
|
2014-05-07 |
2019-12-19 |
Boehringer Ingelheim International Gmbh |
Nebulizer
|
|
US10034866B2
(en)
|
2014-06-19 |
2018-07-31 |
Teva Branded Pharmaceutical Products R&D, Inc. |
Inhalable medicament comprising tiotropium
|
|
RU2577289C1
(ru)
*
|
2015-03-26 |
2016-03-10 |
Шолекс Девелопмент Гмбх |
Аэрозольный препарат на основе фенотерола гидробромида для лечения заболеваний органов дыхания
|
|
WO2018051132A1
(en)
*
|
2016-09-19 |
2018-03-22 |
Mexichem Fluor S.A. De C.V. |
Pharmaceutical composition
|
|
EP3569221A1
(en)
*
|
2018-05-17 |
2019-11-20 |
Notoxins IP B.V. |
Aqueous formulations comprising ipratropium for topical treatment of hyperhidrosis
|
|
US20220040086A1
(en)
*
|
2018-10-01 |
2022-02-10 |
Kindeva Drug Delivery L.P. |
Formulation and aerosol canisters, inhalers, and the like containing the formulation
|
|
WO2020152548A1
(en)
*
|
2019-01-24 |
2020-07-30 |
Glenmark Pharmaceuticals Limited |
Stable aerosol inhalation compositions of formoterol
|
|
GB2584686A
(en)
*
|
2019-06-11 |
2020-12-16 |
Mexichem Fluor Sa De Cv |
Methods
|
|
CN111297835B
(zh)
*
|
2019-12-20 |
2022-11-25 |
上海方予健康医药科技有限公司 |
含抗胆碱能药物的吸入气雾剂及其制备工艺和使用方法
|
|
PE20240629A1
(es)
*
|
2020-10-09 |
2024-03-26 |
Chiesi Farm Spa |
Formulacion farmaceutica para inhalador presurizado de dosis medidas
|